Skip to content

PAS for Post-SCI Neuropathic Pain

Paired Associative Stimulation for Post- Spinal Cord Injury Neuropathic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05362422
Enrollment
5
Registered
2022-05-05
Start date
2022-04-22
Completion date
2023-09-22
Last updated
2023-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain, Spinal Cord Injury Cervical

Brief summary

The investigators have shown in incomplete SCI patients that long-term paired associative stimulation is capable of restoring voluntary control over some paralyzed muscles and enhancing motor output in the weak muscles. In this study, the investigators will administer long-term paired associative stimulation to patients with incomplete cervical level SCI and SCI- associated neuropathic pain, and investigate its effectiveness for neuropathic pain treatment.

Interventions

Paired associative stimulation (PAS) administered 3-5 times per week for 4 weeks to upper limbs. PAS comprises transcranial magnetic stimulation (eXimia magnetic stimulator, Nexstim Ltd, Helsinki, Finland) and peripheral nerve stimulation (given with Dantec Keypoint® electroneuromyography device (Natus Medical Incorporated, Pleasanton, CA, USA)).

DEVICEsham long-term paired associative stimulation

Sham transcranial magnetic stimulation and sham peripheral nerve stimulation.

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* incomplete cervical spinal cord injury * time from injury at least 1.5 years * chronic SCI- induced neuropathic pain in the upper limb

Exclusion criteria

* Diagnosed brain damage, visible in MRI or CT. * No activity in hands/fingers and no MEPs recorded from distal hand muscles. * Epilepsy * Metal inclusion in the head area * High intracranial pressure * Pacemaker * Implanted hearing device * Progressive diseases of spinal cord or brain (e.g. malignant tumors, degenerative diseases). * Previous head or spinal cord injury affecting the motor performance of upper extremities. * Congenital anomaly in the anatomical structure of spinal canal/cord or dura. * Significant systemic disease or other condition that could cause neurological deficit, or may affect subject's capability to undergo investigation-related procedures. * Acute severe infection. * Contraindications for MRI. * Current severe psychiatric diseases. * Current chronic drug and/or alcohol abuse. * Pregnancy. * Pressure ulcer affecting the subject's capability to undergo the procedure safely

Design outcomes

Primary

MeasureTime frameDescription
Brief Pain InventoryChange from baseline at 1 day after the intervention0-10 scale, 0 - no pain, 10 - worst possible pain.
Numeric Rating ScaleChange from baseline at 1 day after the intervention0-10 scale, 0 - no pain, 10 - worst possible pain.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026